(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Electronics
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > Pharmaceuticals & Biotechnology
 
 
Animal Health - 137
Biotechnology - 35
Ethical Pharmaceuticals - 143
Healthcare - 14
Medical Equipment - 58
Pharmaceutical Intermediates - 10
 
 Pharmaceuticals & Biotechnology Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  2  3  4  5  6  7  8  9  10  11  Next »
Report on China's Veterinary Biologics Industry Investment

The report will make a detailed and objective analysis of the development trend of China's veterinary biologics industry, aiming to be of help to the scientific judgment of the investment value of China's veterinary biologics industry.

 

$4000.00
       
Epigenomics Present and Future Applications for Pharmaceuticals and Diagnostics

"Mabs" and molecular tests are among the growth industries of pharmaceuticals and diagnostics, but they may have competition long-term from an unexpected source. Epigenomics is a potential game-changer in the clinical therapeutics market and significant in testing as well....

 

$3995.00
       
Rapid Heart Rates Grow Faster as Drug Treatments Threaten Lives

Major safety fears over supraventricular tachycardia (SVT) medications are threatening many elderly patients, and even encouraging some to opt for surgery, claims a new report by healthcare experts GlobalData.

The new report, "Supraventricular Tachycardia (SVT) Therapeutics - Pipeline Assessment and Market Forecasts to 2019" shows that the prognosis for SVT is good if there are no associated co-morbidities, but with time, more frequent and long-lasting episodes are seen in almost all patients, who are forced to adhere to treatments potentially even more dangerous to their health than the condition itself....


 

$3995.00
       
Epigenetics: Applications for Pharmaceuticals and Diagnostics (Methylation, Histone Modification and miRNA expression)

Epigenetics (“Epi”; “over “ or “above” genetics) is recognized as those systems that control the expression of DNA-coded genes, but do not reside in the base pair sequences of the DNA. Rather, these control mechanisms are based on factors or molecules that bind to specific regions of the DNA (the genome), affecting gene expression....

 

$3995.00
       
Early Toxicology: Markets and Approaches

Early toxicology testing is emerging as one of the mostsignificant areas of drug discovery. Toxicity is no longer something that can be left to the development stage, or just a small part of ADMET....

 

$3995.00
       
What's Next In Vaccines (Malaria, Diabetes, Alzheimer's, Allergies and 30 Other Targets in the 2012-2021 Vaccine Pipeline)

Vaccines are one of the most dynamic parts of the pharmaceutical business today but future growth will depend on a considerable amount of potential vaccines in the pipeline.This Kalorama Information report What's Next in Vaccines?...

 

$3995.00
       
The U.S. Market for Rx to OTC Switches, 6th Edition

The U.S....

 

$3995.00
       
Vaccines 2012 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments

This report examines the market for vaccines used in humans to previous various types of disease. It covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable, such as Alzheimer’s disease, diabetes, Ebola infection, Epstein-Barr virus (EBV) infection, ETEC infection, heart attach, Helicobacter pylori infection, multiple sclerosis, Parkinson’s disease, West Nile virus (WNV) infection, etc....


 

$3995.00
       
The World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral Foods)

This Kalorama Information report - The World Market for Clinical Nutrition Products - focuses on three primary segments of essential medical nutrition:
  • Infant Nutrition: (Milk-based, Soy-based, Special Needs such as Chronic Reflux or Gastrointestinal Discomfort)
  • Enteral Nutrition (Standard and Fiber-containing Elemental and Semi-elemental, Specialized for Chronically Ill Patients)
  • Parenteral Nutrition
For each category, the report provides revenue data and forecasts for the most important segmentations. The report includes incidence of conditions which often require enteral or parenteral feeding, birth rates, over 65 population, and overall global population....

 

$3995.00
       
EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2022

Type 2 diabetes, formerly known as non-insulin dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorder of glucose homeostasis and results from the body’s inability to make use of the available insulin along with relative insulin deficiency (WHO, 2013). This causes excess glucose production by liver cells along with impaired insulin secretion, which leads to an increased blood and urine glucose level....

 

$3995.00
       
EpiCast Report: Asthma - Epidemiology Forecast to 2022

Asthma is one of the most common chronic diseases in the world, with an estimated 300 million people suffering from the disease in 2004 (Masoli et al., 2004)....

 

$3995.00
       
The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment)

This Kalorama Information report The Market for Hospital-Acquired Infection Control (Sterilization, Cleaning, Testing, Treatment) focuses on the market for preventing, testing and treating infections in the healthcare environment.

 

$3995.00
       
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development

There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. Stem cells also have value as a research tool, as their in vitro study would allow scientists to learn more about the function of various organs and the development of particular diseases; stem cells may also eventually permit drug developers to test emerging therapies on diseased cells....

 

$3995.00
       
World Market for Prescription Dermatological Drugs, (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)

This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the eighth time that Kalorama has detailed the various categories of prescription dermatological drugs, describes the global market and identifies major market factors that may help to shape the market for treatments in the future. It is a time of change for this market sector, with OTC product launches, rising skin cancer incidence and acquisitions in the industry, and this report takes those updated details into account in its comprehensive analysis.

Full Coverage of Key Prescription Dermatological Drug Segments

The global market for prescription dermatology drugs includes products in the following categories:

  • Prescription Acne and Rosacea Drugs (Benzoyl, Retinoids, Antibiotics, Other)
  • Prescription Antiaging and Photodamage Drugs (Keratolytics, Moisturizers, Retinoids, Sun-screens, Other Agents)
  • Prescription Dermatitis and Seborrhea Drugs(Topical, Systemic, Others)
  • Prescription Fungal Infection Drugs (Topical, Systemic)
  • Prescription Hair Loss and Hair Removal Drugs(Antiandrogens, Androgen Inhibitors, Others)
  • Prescription Hyperpigmentation/Melasma Drugs(Hyperpigmentation/Melasma Agents, Depigmenting Agents)
  • Prescription Psoriasis Drugs (Topical, Systemic, Other)
  • Prescription Skin Cancer Drugs
  • Other Prescription Skin Disorder Drugs(Antiviral Drugs, Antiparasitic Agents)



 

$3995.00
       
The World Anesthesia Drug Market (General, Local, Adjunctive)

This Kalorama Information report ? The World Anesthesia Drug Market - focuses on three primary segments of anesthesia:
  • General Anesthesia
  • Local Anesthesia
  • Adjunctive Therapies in Anesthesia
The report covers both currently marketed and late stage development anesthesia drugs....

 

$3995.00
       
What's Next In Vaccines in the 2012-2021 Vaccine Pipeline (Malaria, Diabetes, Alzheimer's, Allergies and 30 Other Targets)

Vaccines are one of the most dynamic parts of the pharmaceutical business today but future growth will depend on a considerable amount of potential vaccines in the pipeline.This Kalorama Information report What's Next in Vaccines?...

 

$3995.00
       
The World Market for Cardiovascular Diagnostics

This report, The World Market for Cardiovascular Diagnostics, provides the reader with an overview of the global cardiac diagnostics industry and the trends driving growth. Segments within the cardiac diagnostic market include:

 

$3995.00
       
Trends in Therapeutic Partnering

The Trends in Therapeutic Partnering report provides the most comprehensive and in-depth insight into the 35 most popular therapeutic targets for partnering in the period 2007 to mid 2013.

 

$3995.00
       
« Previous     2  3  4  5  6  7  8  9  10  11   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X